Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are
common in aging men and can significantly affect quality of life. Men with bothersome …

Testosterone is the most abundant androgen in serum. Intracellularly, testosterone is
converted to dihydrotestosterone, the preferred ligand for androgen receptor transactivation …

Objective To compare the cost-effectiveness of surgical interventions for BPH. Methods
Using a Markov model, a cost-utility analysis was performed comparing HoLEP, B-TURP …

Objective. We examined the association between serum uric acid (SUA) level and the
frequency, risk, and cost of gout flares among the elderly. Methods. Data were extracted from …

De COVID-19-epidemie heeft tijdens de eerste golf grote impact gehad op de zorg, vooral in
het voorjaar van 2020. Afspraken, behandelingen en operaties voor niet-COVID-patiënten …

Context The COMBINE (Combined Pharmacotherapies and Behavioral Intervention) clinical
trial recently evaluated the efficacy of medications, behavioral therapies, and their …

OBJECTIVE To compare the costs and effectiveness of treatments for benign prostatic
hyperplasia (BPH), including watchful waiting, pharmaceuticals (α‐blockers, 5‐α‐reductase …

In men with BPH/LUTS, 5ARIs reduce prostate sizes up to 25%, increase Q max
approximately 1 to 3 mL/s, and decrease AUA or IP symptom scores approximately 2 to 5 …

The search for a minimally invasive approach to the treatment of Lower Urinary Tract
Symptoms (LUTS) suggestive of Benign Prostatic Hyperplasia (BPH) is probably as old as …

Objective To determine which surgical treatment for lower urinary tract symptoms suggestive
of benign prostate enlargement is cost effective. Design Care pathways describing credible …